Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001219680 | SCV001391630 | uncertain significance | MEGF10-related myopathy | 2022-02-03 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 932 of the MEGF10 protein (p.Thr932Met). This variant is present in population databases (rs775983100, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with MEGF10-related conditions. ClinVar contains an entry for this variant (Variation ID: 948426). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002562482 | SCV003703778 | uncertain significance | Inborn genetic diseases | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.2795C>T (p.T932M) alteration is located in exon 22 (coding exon 20) of the MEGF10 gene. This alteration results from a C to T substitution at nucleotide position 2795, causing the threonine (T) at amino acid position 932 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003486967 | SCV003810947 | uncertain significance | not provided | 2023-01-17 | criteria provided, single submitter | clinical testing |